Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
What happened
CRISPR Therapeutics (NASDAQ:CRSP) were down 9.1% as of 12:05 p.m. EST.
Editas Medicine (NASDAQ:EDIT) stock had declined 13.7%, while
Intellia Therapeutics (NASDAQ:NTLA) shares had slumped 11.4%.
There wasn t a clear reason behind today s rout of biotech stocks. The biggest negative story in the biopharmaceutical industry centered on
Arcturus Therapeutics disappointing early-stage results for its single-dose COVID-19 vaccine candidate.
Image source: Getty Images.